These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 22991264

  • 1. Chrysin activates Notch1 signaling and suppresses tumor growth of anaplastic thyroid carcinoma in vitro and in vivo.
    Yu XM, Phan T, Patel PN, Jaskula-Sztul R, Chen H.
    Cancer; 2013 Feb 15; 119(4):774-81. PubMed ID: 22991264
    [Abstract] [Full Text] [Related]

  • 2. Hesperetin activates the Notch1 signaling cascade, causes apoptosis, and induces cellular differentiation in anaplastic thyroid cancer.
    Patel PN, Yu XM, Jaskula-Sztul R, Chen H.
    Ann Surg Oncol; 2014 Dec 15; 21 Suppl 4(0 4):S497-504. PubMed ID: 24419754
    [Abstract] [Full Text] [Related]

  • 3. Resveratrol induces differentiation markers expression in anaplastic thyroid carcinoma via activation of Notch1 signaling and suppresses cell growth.
    Yu XM, Jaskula-Sztul R, Ahmed K, Harrison AD, Kunnimalaiyaan M, Chen H.
    Mol Cancer Ther; 2013 Jul 15; 12(7):1276-87. PubMed ID: 23594881
    [Abstract] [Full Text] [Related]

  • 4. Suberoyl bishydroxamic acid activates notch1 signaling and suppresses tumor progression in an animal model of medullary thyroid carcinoma.
    Ning L, Jaskula-Sztul R, Kunnimalaiyaan M, Chen H.
    Ann Surg Oncol; 2008 Sep 15; 15(9):2600-5. PubMed ID: 18563491
    [Abstract] [Full Text] [Related]

  • 5. Antiproliferative effect of chrysin on anaplastic thyroid cancer.
    Phan T, Yu XM, Kunnimalaiyaan M, Chen H.
    J Surg Res; 2011 Sep 15; 170(1):84-8. PubMed ID: 21571321
    [Abstract] [Full Text] [Related]

  • 6. Blocking CDK7-Mediated NOTCH1-cMYC Signaling Attenuates Cancer Stem Cell Activity in Anaplastic Thyroid Cancer.
    Doolittle WKL, Zhao L, Cheng SY.
    Thyroid; 2022 Aug 15; 32(8):937-948. PubMed ID: 35822558
    [Abstract] [Full Text] [Related]

  • 7. Xanthohumol-Mediated Suppression of Notch1 Signaling Is Associated with Antitumor Activity in Human Pancreatic Cancer Cells.
    Kunnimalaiyaan S, Trevino J, Tsai S, Gamblin TC, Kunnimalaiyaan M.
    Mol Cancer Ther; 2015 Jun 15; 14(6):1395-403. PubMed ID: 25887885
    [Abstract] [Full Text] [Related]

  • 8. Suberoyl bis-hydroxamic acid activates Notch1 signaling and induces apoptosis in anaplastic thyroid carcinoma through p53.
    Li J, Zheng X, Gao M, Zhao J, Li Y, Meng X, Qian B, Li J.
    Oncol Rep; 2017 Jan 15; 37(1):458-464. PubMed ID: 28004113
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of gamma-secretase activity impedes uterine serous carcinoma growth in a human xenograft model.
    Groeneweg JW, Hall TR, Zhang L, Kim M, Byron VF, Tambouret R, Sathayanrayanan S, Foster R, Rueda BR, Growdon WB.
    Gynecol Oncol; 2014 Jun 15; 133(3):607-15. PubMed ID: 24667249
    [Abstract] [Full Text] [Related]

  • 10. Xiaotan Sanjie decoction attenuates tumor angiogenesis by manipulating Notch-1-regulated proliferation of gastric cancer stem-like cells.
    Yan B, Liu L, Zhao Y, Xiu LJ, Sun DZ, Liu X, Lu Y, Shi J, Zhang YC, Li YJ, Wang XW, Zhou YQ, Feng SH, Lv C, Wei PK, Qin ZF.
    World J Gastroenterol; 2014 Sep 28; 20(36):13105-18. PubMed ID: 25278704
    [Abstract] [Full Text] [Related]

  • 11. Role of Krüppel-Like Factor 4 in the Maintenance of Chemoresistance of Anaplastic Thyroid Cancer.
    Lee SI, Kim DK, Seo EJ, Choi EJ, Kwon YW, Jang IH, Lee JC, Kim HY, Shong M, Kim JH, Kim SJ.
    Thyroid; 2017 Nov 28; 27(11):1424-1432. PubMed ID: 28920531
    [Abstract] [Full Text] [Related]

  • 12. The EPRS-ATF4-COLI pathway axis is a potential target for anaplastic thyroid carcinoma therapy.
    Mi L, Liu J, Zhang Y, Su A, Tang M, Xing Z, He T, Wei T, Li Z, Wu W.
    Phytomedicine; 2024 Jul 28; 129():155670. PubMed ID: 38704915
    [Abstract] [Full Text] [Related]

  • 13. Curcumin-mediated regulation of Notch1/hairy and enhancer of split-1/survivin: molecular targeting in cholangiocarcinoma.
    Koprowski S, Sokolowski K, Kunnimalaiyaan S, Gamblin TC, Kunnimalaiyaan M.
    J Surg Res; 2015 Oct 28; 198(2):434-40. PubMed ID: 25890434
    [Abstract] [Full Text] [Related]

  • 14. The Role of Notch1 Signaling in Anaplastic Thyroid Carcinoma.
    Kim HJ, Kim MJ, Kim A, Jung CW, Park S, Koh JS, Myung JK.
    Cancer Res Treat; 2017 Apr 28; 49(2):509-517. PubMed ID: 27586674
    [Abstract] [Full Text] [Related]

  • 15. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
    So JY, Wahler J, Das Gupta S, Salerno DM, Maehr H, Uskokovic M, Suh N.
    J Steroid Biochem Mol Biol; 2015 Apr 28; 148():111-21. PubMed ID: 25541438
    [Abstract] [Full Text] [Related]

  • 16. Suberoyl bis-hydroxamic acid activates Notch-1 signaling and induces apoptosis in medullary thyroid carcinoma cells.
    Ning L, Greenblatt DY, Kunnimalaiyaan M, Chen H.
    Oncologist; 2008 Feb 28; 13(2):98-104. PubMed ID: 18305053
    [Abstract] [Full Text] [Related]

  • 17. Ophiopogonin D' inhibited tumour growth and metastasis of anaplastic thyroid cancer by modulating JUN/RGS4 signalling.
    Xu T, Zhang W, Zhang Y, Song F, Huang P.
    J Cell Mol Med; 2024 Aug 28; 28(16):e70014. PubMed ID: 39153211
    [Abstract] [Full Text] [Related]

  • 18. Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis.
    Sadowski SM, Boufraqech M, Zhang L, Mehta A, Kapur P, Zhang Y, Li Z, Shen M, Kebebew E.
    Oncotarget; 2015 Jul 20; 6(20):18038-49. PubMed ID: 25945839
    [Abstract] [Full Text] [Related]

  • 19. Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo.
    Ferrari SM, Bocci G, Di Desidero T, Elia G, Ruffilli I, Ragusa F, Orlandi P, Paparo SR, Patrizio A, Piaggi S, La Motta C, Ulisse S, Baldini E, Materazzi G, Miccoli P, Antonelli A, Fallahi P.
    Oncol Rep; 2018 May 20; 39(5):2225-2234. PubMed ID: 29517103
    [Abstract] [Full Text] [Related]

  • 20. CRSP8 promotes thyroid cancer progression by antagonizing IKKα-induced cell differentiation.
    Liao Y, Hua Y, Li Y, Zhang C, Yu W, Guo P, Zou K, Li W, Sun Y, Wang R, Zuo Y, Sui S, Tian C, Hao J, Chen M, Hu S, Chen M, Long Q, Wang X, Zou L, Xie F, Guo W, Deng W.
    Cell Death Differ; 2021 Apr 20; 28(4):1347-1363. PubMed ID: 33162555
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.